Piper Sandler upgrades Guardant Health, says shares can rall

The analyst said Guardant Health's recent stock sell-off is a "compelling opportunity" for investors, as the company is the market leader in liquid biopsy. 

Related Keywords

Piper Sandler , David Westenberg , Guardant Health , Drug Administration , Guardant Reveal , Natera Inc , Markets , Investment Strategy , Stock Markets , Guardant Health Inc , Breaking News Markets , Business News ,